MedPath

Comparison of Risperidone or Aripiprazole addition to Selective Serotonin Reuptake Inhibitors for treating Obsessive Compulsive Disorder

Not Applicable
Conditions
Health Condition 1: F422- Mixed obsessional thoughts and acts
Registration Number
CTRI/2024/06/069483
Lead Sponsor
Government Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients fulfilling the criteria for OCD as per ICD-11 and on treatment with a dose within therapeutic range for one or more than one SSRIs for 12 weeks and current YBOCS =16

Exclusion Criteria

1. Patients with evidence of dementia, organic brain disorders like epilepsy, tumours,

neurological lesions, stroke

2. Patients on Tricyclic Antidepressants

3. Patients with Intellectual Disability

4. Patients with substance dependence except nicotine and caffeine

5. Patients with co-morbid major mental illness

6. Past history of augmentation with risperidone or aripiprazole

7. History of hypersensitivity/allergic reaction to risperidone and aripiprazole

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath